Common Stock, Shares, Outstanding of PDS Biotechnology Corp from 31 Dec 2014 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
PDS Biotechnology Corp quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2014 to 30 Sep 2025.
  • PDS Biotechnology Corp Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 47,705,442, a 30% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

PDS Biotechnology Corp Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 47,705,442 +10,885,632 +30% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 46,633,362 +9,854,087 +27% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 45,445,851 +8,766,576 +24% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 37,987,380 +4,892,859 +15% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 36,819,810 +5,812,047 +19% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 36,779,275 +5,911,087 +19% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 36,679,275 +5,955,665 +19% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 33,094,521 +2,924,204 +9.7% 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q3 2023 31,007,763 +2,549,075 +9% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 30,868,188 +2,409,500 +8.5% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 30,723,610 +2,272,716 +8% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 30,170,317 +1,721,705 +6.1% 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 28,458,688 +23,621 +0.08% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 28,458,688 +40,779 +0.14% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 28,450,894 +6,172,633 +28% 31 Mar 2022 10-Q 11 May 2022 2022 Q1
Q4 2021 28,448,612 +6,186,993 +28% 31 Dec 2021 10-K 28 Mar 2023 2022 FY
Q3 2021 28,435,067 +6,173,448 +28% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 28,417,909 +13,056,290 +85% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 22,278,261 +6,927,816 +45% 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 22,261,619 +16,980,382 +322% 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q3 2020 22,261,619 +16,982,769 +322% 30 Sep 2020 10-Q 13 Nov 2020 2020 Q3
Q2 2020 15,361,619 +10,184,132 +197% 30 Jun 2020 10-Q 13 Aug 2020 2020 Q2
Q1 2020 15,350,445 +10,177,507 +197% 31 Mar 2020 10-Q 13 May 2020 2020 Q1
Q4 2019 5,281,237 +1,864,050 +55% 31 Dec 2019 10-K 18 Mar 2021 2020 FY
Q3 2019 5,278,850 -26,049,278 -83% 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 5,177,487 -26,150,641 -83% 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 5,172,938 -26,073,293 -83% 31 Mar 2019 10-Q 14 May 2019 2019 Q1
Q4 2018 3,417,187 -27,452,018 -89% 31 Dec 2018 10-K 27 Mar 2020 2019 FY
Q3 2018 31,328,128 +468,928 +1.5% 30 Sep 2018 10-Q 01 Nov 2018 2018 Q3
Q2 2018 31,328,128 +498,864 +1.6% 30 Jun 2018 10-Q 01 Aug 2018 2018 Q2
Q1 2018 31,246,231 +2,234,795 +7.7% 31 Mar 2018 10-Q 01 May 2018 2018 Q1
Q4 2017 30,869,205 +1,950,689 +6.7% 31 Dec 2017 10-K 21 Feb 2019 2018 FY
Q3 2017 30,859,200 +1,943,974 +6.7% 30 Sep 2017 10-Q 01 Nov 2017 2017 Q3
Q2 2017 30,829,264 +1,979,818 +6.9% 30 Jun 2017 10-Q 01 Aug 2017 2017 Q2
Q1 2017 29,011,436 +198,216 +0.69% 31 Mar 2017 10-Q 03 May 2017 2017 Q1
Q4 2016 28,918,516 +107,671 +0.37% 31 Dec 2016 10-K 01 Mar 2018 2017 FY
Q3 2016 28,915,226 +27,226,751 +1613% 30 Sep 2016 10-Q 01 Nov 2016 2016 Q3
Q2 2016 28,849,446 30 Jun 2016 10-Q 03 Aug 2016 2016 Q2
Q1 2016 28,813,220 31 Mar 2016 10-Q 03 May 2016 2016 Q1
Q4 2015 28,810,845 +27,122,370 +1606% 31 Dec 2015 10-K 02 Mar 2017 2016 FY
Q3 2015 1,688,475 30 Sep 2015 10-Q 06 Nov 2015 2015 Q3
Q4 2014 1,688,475 31 Dec 2014 10-K 08 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.